title: What is the promise of nicotinergic compounds in schizophrenia treatment?
authors.affiliation: Department of Psychiatry & Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
authors.forename: Juliane K
authors.initials: JK
authors.lastname: Mueller
authors.affiliation: Department of Psychiatry & Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
authors.forename: Cathrin
authors.initials: C
authors.lastname: Rohleder
authors.affiliation: Department of Psychiatry & Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
authors.forename: F Markus
authors.initials: FM
authors.lastname: Leweke
keywords: clinical trials; cognition; nicotinic acetylcholine receptor